A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders (HPDSC)

Celgene

Status: Unknown

Conditions: Hematologic Malignancies

Treatments: Procedure: UCB and HPDSC

Study type: Observational

Funder types: Industry

Identifiers

NCT00596999

CCT-HPDSC-001

Details and patient eligibility

About

To investigate the safety of partially matched related human placental-derived stem cells (HPDSC) administered in conjunction with umbilical cord blood (UCB) stem cells from the same donor in subjects with various malignant or nonmalignant disorders potentially curable with stem cell transplantation and to assess potential restoration of normal hematopoiesis and immune function in subjects with these disorders

Enrollment: 6 estimated patients

Sex: All

Ages: Under 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• suitable UCB collected from partially or fully HLA matched related donor
• subject requires umbilical cord transplantation

Exclusion criteria

• any condition, including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study
• major anticipated illness or organ failure incompatible with survival from stem cell transplant

Trial design

6 participants in 1 patient group

1

Description:

all subjects will be treated with UCB and HPDSC

Treatment:

Procedure: UCB and HPDSC